MARKER THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $9.86M.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $9.86M, a 26629.94% increase from fiscal 2024.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $36.90K, a 96.36% decline from fiscal 2023.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $1.01M, a 401.97% increase from fiscal 2022.
- MARKER THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $202.13K, a 99.62% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $9.86M 10-K · filed 2026-03-18 |
| 2025-09-30 | $9.86M 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $36.90K 10-K · filed 2026-03-18 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2024-06-30 | $36.90K 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.01M 10-K · filed 2025-03-31 |
| 2023-09-30 | $394.67K 10-Q · filed 2024-11-14 | $1.15M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $758.53K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $619.97K 10-Q · filed 2024-05-15 | $822.10K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $138.56K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $202.13K 10-K · filed 2024-03-26 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-06-30 | $63.57K 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $52.55M 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $56.55M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $58.74M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $52.55M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $6.19M 10-K · filed 2022-03-17 |
| 2020-09-30 | $2.19M 10-Q · filed 2021-11-10 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $3.14M 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |